Klifo
Private Company
Funding information not available
Overview
Klifo is a well-established, private service provider in the biopharma ecosystem, specializing in drug development strategy and clinical trial supply execution. The company operates as a strategic partner, leveraging decades of experience to help clients navigate complex development pathways and ensure reliable delivery of clinical supplies globally. Its business model is entirely service-based, generating revenue through consultancy fees and operational service contracts, positioning it as an enabler for other therapeutic companies rather than a developer of its own assets.
Technology Platform
Accumulated drug development intellectual capital and proprietary methodologies for clinical trial supply chain strategy and execution. A knowledge-based platform for regulatory strategy, clinical design, and operational logistics.
Opportunities
Risk Factors
Competitive Landscape
Klifo competes with large, full-service global Contract Research Organizations (CROs) like IQVIA and Parexel, as well as niche drug development consultancies and specialized clinical trial supply logistics providers. Its differentiation lies in its integrated European-focused advisory and hands-on supply chain execution.